Worldwide Dried Blood Spot Collection Cards Industry to 2027 - Increasing Demand in Several Applications Presents Opportunities

Dublin, Feb. 19, 2021 (GLOBE NEWSWIRE) -- The "Dried Blood Spot Collection Cards Market Share, Size, Trends, Industry Analysis Report, By Type; By Application; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

The global dried blood spot collection cards market expected to reach USD 339.5 million by 2027, according to the study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The recent surge in COVID-19 pandemic, rising newborn screening through dried blood spot collection cards for hereditary and metabolic disorders, innovations, and its wide applicability in diagnosing varied diseases coupled with new product launches are few factors attributed to the market growth for dried blood spot collection cards. For instance, in June 2020, PerkinElmer Inc. introduced the DBS test for COVID-19 in the market utilizing its DELFIA platform with a capacity of up to 5,000 samples in a day. This sample collection allows both de-centralized collection and efficient testing.

The global dried blood spot collection cards industry is fragmented based on card type, application, and region. In terms of card type, the market is segmented into Whatman 903, Ahlstrom 226, FTA, and others. Based on application, the global dried blood spot collection cards industry is further bifurcated into newborn screening, infectious disease testing, therapeutic drug monitoring, forensics, and other applications.

Segment Highlights

• The Whatman 903 dried blood spot collection cards industry segment accounted for the largest revenue share in 2019 owing to the emergence and increasing incidences of genetic disorders. The market segment held over 25% of the global share in 2019.

• Based on application, the new-born screening dried blood spot collection cards industry segment is projected to constitute almost half of the market in 2027. The recent surge in neo-natal disorders is expected to be primarily responsible for the market segment's growth over the forecast period.

• North American dried blood spot collection cards industry accounted for the largest share in terms of revenue in 2019. The region has a well developed medical infrastructure and government-sponsored newborn screening programs, which drives the market demand for such products.

• Qiagen, PerkinElmer, and Roche Diagnostics are a few of the major market players operating in the dried blood spot collection cards industry. Increasing research & development and a wide range of product offerings are a few prominent strategies adopted by the dried blood spot collection cards industry players.

Key Topics Covered:

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Dried Blood Spot Collection Cards Market Insights
4.1. Dried Blood Spot Collection Cards - Industry snapshot
4.2. Dried Blood Spot Collection Cards Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing demand in several applications
4.2.1.2. Easy collection and storage
4.2.2. Restraints and Challenges
4.2.2.1. Contamination risks
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Dried Blood Spot Collection Cards Market Industry trends

5. Dried Blood Spot Collection Cards Market Assessment by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Dried Blood Spot Collection Cards Market, By Type, 2016-2027 (USD Million)
5.3. Whatman 903
5.3.1. Global Dried Blood Spot Collection Cards Market, by Whatman 903, by Region, 2016-2027 (USD Million)
5.4. Ahlstrom 226
5.4.1. Global Dried Blood Spot Collection Cards Market, by Ahlstrom 226, by Region, 2016-2027 (USD Million)
5.5. FTA Cards
5.5.1. Global Dried Blood Spot Collection Cards Market, by FTA Cards, by Region, 2016-2027 (USD Million)
5.6. Others
5.6.1. Global Dried Blood Spot Collection Cards Market, by Other Types, by Region, 2016-2027 (USD Million)

6. Global Dried Blood Spot Collection Cards Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Global Dried Blood Spot Collection Cards Market, By Application, 2016-2027 (USD Million)
6.3. Newborn Screening
6.3.1. Global Dried Blood Spot Collection Cards Market, by Newborn Screening, By Region, 2016-2027 (USD Million)
6.4. Infectious Disease Testing
6.4.1. Global Dried Blood Spot Collection Cards Market, by Infectious Disease Testing, by Region, 2016-2027 (USD Million)
6.5. Therapeutic Drug Monitoring
6.5.1. Global Dried Blood Spot Collection Cards Market, by Therapeutic Drug Monitoring, by Region, 2016-2027 (USD Million)
6.6. Forensics
6.6.1. Global Dried Blood Spot Collection Cards Market, by Forensics, by Region, 2016-2027 (USD Million)
6.7. Others
6.7.1. Global Dried Blood Spot Collection Cards Market, by Other Applications, by Region, 2016-2027 (USD Million)

7. Dried Blood Spot Collection Cards Market Assessment by Geography
7.1. Key findings
7.2. Introduction
7.3. Dried Blood Spot Collection Cards Market - North America
7.4. Dried Blood Spot Collection Cards Market - Europe
7.5. Dried Blood Spot Collection Cards Market - Asia-Pacific
7.6. Dried Blood Spot Collection Cards Market - Middle East & Africa
7.7. Dried Blood Spot Collection Cards Market - Latin America

8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisition
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles
9.1. Qiagen
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Developments
9.2. PerkinElmer
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Developments
9.3. Roche
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Developments
9.4. Shimazdu (Novilytic Labs)
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Developments
9.5. Ahlstrom-Munksjo
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Developments
9.6. Pall Corporation
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Developments
9.7. Eastern Business Forms, Inc.
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Developments
9.8. ARCHIMEDlife
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Developments
9.9. Centogene AG
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Types/Product Benchmarking
9.9.4. Recent Developments

For more information about this report visit https://www.researchandmarkets.com/r/9y512e

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900